Anxiety symptoms predict head and neck cancer survival: Exploring mediation by systemic inflammation and tumor response to treatment
Psycho-Oncology · 2024
DOI: 10.1002/pon.6375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psycho-Oncology, 2024. Verfasst von Hannah Houston und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Louisville School of Medicine, Louisville, Kentucky, USA. Hauptthemen laut MEDLINE: Anxiety, Head and Neck Neoplasms, Inflammation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Background
Head and neck cancers (HNC) are associated with high rates of anxiety. Anxiety has been linked to biological pathways implicated in cancer progression, though little is known about its effects on overall survival. We hypothesized that higher pretreatment anxiety levels in patients with HNC would predict poorer 2‐year overall survival and expected this relationship to be mediated by both systemic inflammation and tumor response to treatment.
Methods
Patients ( N = 394) reported anxiety symptomatology via the GAD‐7 at treatment planning. Pre‐treatment hematology workup provided an index of systemic inflammation (SII; N = 292). Clinical data review yielded tumor response and overall survival. Logistic and multiple regressions and Cox proportional hazard models tested hypothesized relationships.
Results
Higher pretreatment anxiety levels were significantly associated with poorer 2‐year survival (hazard ratio [HR], 1.039; 95% confidence interval [CI], 1.014–1.066, p = 0.002). The association between anxiety and SII was not significant, though anxiety was associated with poorer tumor response (odds ratio [OR], 1.033; 95% CI, 1.001–1.066, p = 0.043). Tumor response fully mediated the relationship between anxiety symptoms and 2‐year survival (HR, 9.290, 95% CI, 6.152–14.031, p < 0.001).
Conclusions
Anxiety was associated with overall survival. Tumor response, but not systemic inflammation, emerged as a potential biological pathway mediating this effect. Screening for anxiety may be beneficial to help prospectively address these concerns and ameliorate potentially detrimental impact on clinically meaningful cancer outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Louisville School of Medicine, Louisville, Kentucky, USA.
- Department of Otolaryngology - Head and Neck Surgery and Communicative Disorders, University of Louisville School of Medicine, Louisville, Kentucky, USA.
- UofL Health - Brown Cancer Center, Louisville, Kentucky, USA.
ORCID-Profile: Isak Beck, Baylee Polzin, Elizabeth Cash
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NIH HHS
- National Cancer Institute
- National Institutes of Health
- National Institute of General Medical Sciences
Zitieren
APA
Houston, H., Beck, I., Albert, C., Palmer, I., Polzin, B., Kabithe, A., Crawford, D., Bumpous, J. M., & Cash, E. (2024). Anxiety symptoms predict head and neck cancer survival: Exploring mediation by systemic inflammation and tumor response to treatment. Psycho-Oncology. https://doi.org/10.1002/pon.6375
Vancouver
Houston H, Beck I, Albert C, Palmer I, Polzin B, Kabithe A, et al. Anxiety symptoms predict head and neck cancer survival: Exploring mediation by systemic inflammation and tumor response to treatment. Psycho-Oncology. 2024. doi:10.1002/pon.6375
BibTeX
@article{Houston2024,
author = {Houston, Hannah and Beck, Isak and Albert, Christy and Palmer, Iona and Polzin, Baylee and Kabithe, Alyssa and Crawford, Devaughn and Bumpous, Jeffrey M and Cash, Elizabeth},
title = {Anxiety symptoms predict head and neck cancer survival: Exploring mediation by systemic inflammation and tumor response to treatment},
journal = {Psycho-Oncology},
year = {2024},
doi = {10.1002/pon.6375}
}
EUVIMED